Additionally, another exception occurred while executing the custom error page for the first exception. The resource you are looking for (or one of its dependencies) could have been removed, had its name changed, or is temporarily unavailable. Incidence of alopecia with plaquenil Methotrexate plaquenil prednisone About eye health checks for people taking hydroxychloroquine. No one need face macular degeneration alone. For information and support call 0300 3030 111. Eye screening for patients taking hydroxychloroquine Plaquenil® I was told from the start by my rheumatologist I would have to have eye exams including visual field exams every six months due to the plaquenil therapy. My first two exams did include these tests. But my next six month appointment is coming up, and they told me I didn't need the visual field test this time so the appointment would be shorter. How to Succeed in Plaquenil Screenings The spectrum of OCT findings associated with the medication can make incorporating the 2016 guidelines harder than you think. Here’s help. By Marlon Demeritt, OD, Sherrol Reynolds, OD, Diana Shechtman, OD, and Jennifer Davidson, OD Hydroxychloroquine (Plaquenil) is considered a disease-modifying anti-rheumatic drug (DMARD). Please review the following URL and make sure that it is spelled correctly. Plaquenil eye exam protocol Plaquenil and eye exams" Lupus Community - Support Group, Plaquenil therapy and eye exams. - Eye Care - MedHelp Chloroquine dna supercoiling Plaquenil is a pretty widely used drug so I figure she should have an opinion on it. I would feel more comfortable having the baseline exam done first BUT I am pretty eager to get started on it ASAP as my eye is starting to bug me due to the morphea that is slowly spreading. Starting Plaquenil BEFORE Eye Exam? - Scleroderma - Inspire. How to Succeed in Plaquenil Screenings. Hydroxychloroquine And Chloroquine Screening 2016 AAO.. Plaquenil Examination. Plaquenil is a drug routinely prescribed for rheumatoid arthritis and lupus. Plaquenil has long been associated with retinal toxicity which can lead to vision loss. In particular it affects the macular region of the retina which is responsible for central vision. The classic lesion is described as a “bull’s eye” with relative hypo pigmentation surrounding a central area of hyper pigmentation, but this is a late finding and many time patients suffer from irreversible vision loss. The goal for Plaquenil Screening to detect toxicity early and stop the medication as soon as possible if present. As a treatment for sarcoidosis, the antimalarial drug hydroxychloroquine Plaquenil® is most likely to be effective in patients with dermatologic involve-ment, joint manifestations and hypercalcemia. Due to poten-tial macular toxicity, it is recommended that patients on hydroxychloroquine have an eye examination every 6-12 months. Methotrexate.